Background: Monitoring CYP2E1 levels in alcoholic individuals holds inheren
t appeal because such determinations might indicate individuals at increase
d risk for alcoholic liver disease. We previously demonstrated that lymphoc
yte CYP2E1 expression reflects in vivo activity of the hepatic enzyme.
Methods: To further validate this approach, the current investigation compa
red lymphocyte CYP2E1 content and chlorzoxazone pharmacokinetics in 51 alco
holic and nonalcoholic White, Navajo, and Mexican American subjects. After
an oral dose of chlorzoxazone, blood samples were collected and lymphocytes
isolated.
Results: Alcoholics exhibited a 2-fold elevation in lymphocyte CYP2E1 messe
nger ribonucleic acid (mRNA) and protein compared to nonalcoholics. Chlorzo
xazone clearance rates were 1.9-fold higher and area under the concentratio
n curve (AUC) values 1.8-fold lower in alcoholic individuals compared to no
nalcoholics. Furthermore, chlorzoxazone clearance rates correlated (I = 0.5
5, p < 0.01, n = 38) with lymphocyte CYP2E1 mRNA content, and transcript le
vels further correlated (r = 0.52, p < 0.001, n = 38) with CYP2E1 protein c
ontent. To compare phenotype with genotype, restriction fragment length pol
ymorphism analyses on deoxyribonucleic acid samples were performed to ident
ify polymorphisms in the CYP2E1 gene. No subjects were homozygous for rare
alleles c2 or C. Nonetheless, 27% of the Navajos and 15% of the Mexican Ame
ricans were heterozygous for the c2 allele. Two White subjects appeared het
erozygous (c1/c2) when RsaI was used to characterize CYP2E1 genotype but ho
mozygous (c1/c1) at the PstI locus. Fifteen percent of Mexican American sub
jects, 20% of Navajo subjects, and 6% of White subjects were heterozygous f
or the C allele. Neither CD nor c1/c2 genotypes were associated with alcoho
lism.
Conclusions: Human lymphocyte CYP2E1 mRNA levels may be useful predictors o
f alcohol-mediated alterations in hepatic CYP2E1 activity. Moreover, ethnic
ity does not appear to play a major role in the levels of expression of lym
phocyte CYP2E1.